0001610717-23-000309.txt : 20231013
0001610717-23-000309.hdr.sgml : 20231013
20231013162031
ACCESSION NUMBER: 0001610717-23-000309
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231011
FILED AS OF DATE: 20231013
DATE AS OF CHANGE: 20231013
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelsey Stephen Michael
CENTRAL INDEX KEY: 0001462808
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39219
FILM NUMBER: 231325280
MAIL ADDRESS:
STREET 1: C/O GERON CORPORATION
STREET 2: 230 CONSTITUTION DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revolution Medicines, Inc.
CENTRAL INDEX KEY: 0001628171
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 472029180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 SAGINAW DR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 415-766-3638
MAIL ADDRESS:
STREET 1: 700 SAGINAW DR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
form4.xml
X0508
4
2023-10-11
0001628171
Revolution Medicines, Inc.
RVMD
0001462808
Kelsey Stephen Michael
C/O REVOLUTION MEDICINES, INC.
700 SAGINAW DRIVE
REDWOOD CITY
CA
94063
true
See Remarks
true
Common Stock
2023-10-11
4
S
0
16667
29.0472
D
273721
D
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 14, 2022.
The transaction was executed in multiple trades in prices ranging from $29.00 to $29.20, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Includes 64,875 restricted stock units.
President, Research and Development
/s/ Jack Anders, as Attorney-in-fact for Stephen Michael Kelsey
2023-10-13